Neuronal growth factors may exert a neuroprotective effect in multiple sclerosis (MS). We found reduced levels of brain-derived neurotrophic factors (BDNF) in the serum and CSF of relapsing-remitting MS patients, which was reversed by therapy with glatiramer acetate. BDNF may play a protective role in MS, and immunomodulation therapy, such as with glatiramer acetate, may enhance the action this...

Abstract Coronary artery aneurysms in children were observed as a rare complication associated with coronavirus disease 2019 (COVID-19). This case report describes the severe end of spectrum new multisystem inflammatory syndrome 12-year-old child coronary aneurysms, myocardial dysfunction, and shock, managed successfully extracorporeal membrane oxygenation support immunomodulation therapy. also...

The use of immunomodulation to treat malignancies has seen a recent explosion in interest. The therapeutic appeal of these treatments is far reaching, and many new applications continue to evolve. In particular, immune modulating drugs have the potential to enhance the systemic anticancer immune effects induced by locoregional thermal ablation. The immune responses induced by ablation monothera...

Our report concerns the observations made during treatment of pneumonia with individually selected bacteriophages in HCAI patients on mechanical ventilation. 19 ventilation whose condition was complicated by antibiotic-resistant were examined. The supplemented phage therapy, for each patient, taking into account microbial etiology disease (Pseudomonas aeruginosa, Кlebsiella pneumoniae, Acinetob...

Objective: To analyze the scientific evidence from studies on effectiveness of immunomodulation in cancer. Methodology: This is a systematic review that searched for respective databases such as Pubmed, Scopus, Cinahl, Web Science, and The Cochrane Data Base, using descriptors English, selected Medical Subject Headings- MeSH. Soon after cataloging, were analyzed through Consolidated Standards R...